Latest Manufacturing News

Page 94 of 263
Telix Pharmaceuticals has met its upgraded FY 2025 revenue guidance with US$804 million, driven by strong growth in its Precision Medicine segment and the successful US launch of Gozellix. The company also advanced multiple clinical trials and announced a strategic collaboration with Varian to combine radiopharmaceuticals with radiation therapy.
Ada Torres
Ada Torres
20 Jan 2026
Fulcrum Lithium has secured permits for an extensive Phase 3 drilling program at its Alkali Flats project in Nevada, aiming to expand and refine its lithium resource amid a robust market rally.
Maxwell Dee
Maxwell Dee
20 Jan 2026
ARB Corporation’s half-year results reveal a modest sales dip driven by Australian OEM challenges, while robust US export growth offers a silver lining.
Victor Sage
Victor Sage
20 Jan 2026
Nanoveu Limited has raised A$7.5 million through a strategic placement to accelerate the commercial rollout of its cutting-edge EMASS ECS-DoT semiconductor technology, including a rapid 16nm chip tape-out and live drone validation.
Sophie Babbage
Sophie Babbage
20 Jan 2026
FBR Limited has secured a binding conditional purchase order worth AUD 990,000 from a leading US heavy equipment dealer for its Mantis welding robot, marking a significant milestone during its prototyping phase.
Victor Sage
Victor Sage
20 Jan 2026
Australian Rare Earths has demonstrated a low-risk, scalable process producing a high-purity mixed rare earth oxide with 99.9% recovery, positioning its Koppamurra project as a strategic supplier amid tightening global rare earth markets.
Maxwell Dee
Maxwell Dee
20 Jan 2026
Mastermyne Group has extended its exclusive distribution agreement with Jennmar Holdings for critical strata consolidation products by a decade, locking in supply until 2047. This move strengthens its foothold in the Australian underground coal mining sector.
Maxwell Dee
Maxwell Dee
20 Jan 2026
Vinyl Group Ltd has reported a landmark quarter with record cash receipts up 80% quarter-on-quarter and its first operating cash flow positive result, signalling a turning point for the music and culture company.
Victor Sage
Victor Sage
20 Jan 2026
Cambium Bio has locked in a A$2.4 million strategic investment from Zheng Yang Biomedical Technology, reinforcing its push into pivotal Phase 3 trials for its dry eye disease treatment.
Ada Torres
Ada Torres
20 Jan 2026
Fletcher Building has agreed to sell its Construction Division to global giant VINCI Construction for an initial $315.6 million, with potential to rise to $334.1 million. The move marks a strategic pivot towards focused building products manufacturing.
Victor Sage
Victor Sage
20 Jan 2026
DXN Limited has signed a strategic MOU with Super Sistem Indonesia to form a joint venture targeting Indonesia’s rapidly expanding digital infrastructure market, aiming for US$7 million in revenue over three years.
Sophie Babbage
Sophie Babbage
19 Jan 2026
Mesoblast has received encouraging feedback from the FDA on its cell therapy rexlemestrocel-L, showing meaningful pain relief and potential opioid use reduction in chronic low back pain patients. The company’s ongoing Phase 3 trial aims to confirm these benefits and advance regulatory approval.
Ada Torres
Ada Torres
19 Jan 2026